842 related articles for article (PubMed ID: 15130900)
1. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
Knight A; Askling J; Granath F; Sparen P; Ekbom A
Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
[TBL] [Abstract][Full Text] [Related]
2. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.
Faurschou M; Sorensen IJ; Mellemkjaer L; Loft AG; Thomsen BS; Tvede N; Baslund B
J Rheumatol; 2008 Jan; 35(1):100-5. PubMed ID: 17937462
[TBL] [Abstract][Full Text] [Related]
3. Urinary bladder cancer in Wegener's granulomatosis: is it more than cyclophosphamide?
Hellmich B; Kausch I; Doehn C; Jocham D; Holl-Ulrich K; Gross WL
Ann Rheum Dis; 2004 Oct; 63(10):1183-5. PubMed ID: 15361369
[No Abstract] [Full Text] [Related]
4. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
Koldingsnes W; Nossent JC
J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
[TBL] [Abstract][Full Text] [Related]
5. Occupational risk factors for Wegener's granulomatosis: a case-control study.
Knight A; Sandin S; Askling J
Ann Rheum Dis; 2010 Apr; 69(4):737-40. PubMed ID: 19364729
[TBL] [Abstract][Full Text] [Related]
6. Leiomyosarcoma of urinary bladder following cyclophosphamide therapy: report of two cases.
Tanguay C; Harvey I; Houde M; Srigley JR; Têtu B
Mod Pathol; 2003 May; 16(5):512-4. PubMed ID: 12748258
[TBL] [Abstract][Full Text] [Related]
7. Etanercept plus standard therapy for Wegener's granulomatosis.
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
[TBL] [Abstract][Full Text] [Related]
8. [Carcinoma of the urinary bladder in a patient receiving cyclophosphamide for Wegener's granuloma: a case report].
Shiba T; Noguchi S; Yao M; Takahashi T; Shuin T; Miura T; Kinoshita Y; Kubota Y; Hosaka M
Hinyokika Kiyo; 1991 Apr; 37(4):393-6. PubMed ID: 1891999
[TBL] [Abstract][Full Text] [Related]
9. Cystitis, bladder cancer, and myelodysplasia in patients with Wegener's granulomatosis: comment on the article by Reinhold-Keller et al.
Sneller MC
Arthritis Rheum; 2000 Dec; 43(12):2853-5. PubMed ID: 11145048
[No Abstract] [Full Text] [Related]
10. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
[TBL] [Abstract][Full Text] [Related]
11. Cancer preceding Wegener's granulomatosis: a case-control study.
Faurschou M; Mellemkjaer L; Sorensen IJ; Thomsen BS; Dreyer L; Baslund B
Rheumatology (Oxford); 2009 Apr; 48(4):421-4. PubMed ID: 19213850
[TBL] [Abstract][Full Text] [Related]
12. [A case of pulmonary metastases from bladder cancer, suspected of recurrent Wegener's granulomatosis].
Sekiya M; Ichikawa M; Tsutsui A; Yoshimi K; Suzuki T; Seyama K; Uekusa T; Takahashi K
Nihon Kokyuki Gakkai Zasshi; 2009 Oct; 47(10):943-6. PubMed ID: 19882920
[TBL] [Abstract][Full Text] [Related]
13. [Cyclophosphamide-induced bladder cancer: three case reports].
Kijima T; Masuda H; Suzuki M; Okada Y; Yano M; Hyochi N; Fujii Y; Kawakami S; Hayashi T; Kobayashi T; Kihara K
Hinyokika Kiyo; 2003 Aug; 49(8):483-6. PubMed ID: 14518387
[TBL] [Abstract][Full Text] [Related]
14. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors.
Wung PK; Holbrook JT; Hoffman GS; Tibbs AK; Specks U; Min YI; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune J; Ytterberg SR; Allen NB; Stone JH;
Am J Med; 2005 Dec; 118(12):1416. PubMed ID: 16378799
[TBL] [Abstract][Full Text] [Related]
15. Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis.
Knight A; Askling J; Ekbom A
Int J Cancer; 2002 Jul; 100(1):82-5. PubMed ID: 12115591
[TBL] [Abstract][Full Text] [Related]
16. [Wegener's granulomatosis and microscopic polyangiitis].
Pagnoux C
Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
Tervaert JW; Stegeman CA
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
[TBL] [Abstract][Full Text] [Related]
18. Wegener's granulomatosis presenting as unilateral parotid enlargement.
Chegar BE; Kelley RT
Laryngoscope; 2004 Oct; 114(10):1730-3. PubMed ID: 15454762
[TBL] [Abstract][Full Text] [Related]
19. Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis.
Faurschou M; Mellemkjaer L; Sorensen IJ; Svalgaard Thomsen B; Dreyer L; Baslund B
Arthritis Rheum; 2009 Apr; 60(4):1187-92. PubMed ID: 19333952
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin's lymphoma in a patient treated for Wegener's granulomatosis with cyclophosphamide and azathioprine.
Colburn KK; Cao JD; Krick EH; Mortensen SE; Wong LG
J Rheumatol; 1985 Jun; 12(3):599-602. PubMed ID: 4045860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
